Seeking a fine balance between effective antithrombotic prophylaxis and safety drug profile in the elderly population: the special case of traumatic brain injury
Acta Neurochir (Wien)
.
2023 Aug;165(8):2215-2218.
doi: 10.1007/s00701-023-05699-z.
Epub 2023 Jul 7.
Authors
Laura Ganau
1
,
Nikolaos Syrmos
2
,
Gianfranco K I Ligarotti
3
,
Mario Ganau
4
Affiliations
1
School of Medicine, University of Cagliari, Cagliari, Italy.
2
School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece.
3
Institute of Aerospace Medicine, Milan, Italy.
4
Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK. Mario.Ganau@alumni.harvard.edu.
PMID:
37418042
DOI:
10.1007/s00701-023-05699-z
No abstract available
Publication types
Letter
MeSH terms
Aged
Brain Injuries*
Brain Injuries, Traumatic* / drug therapy
Fibrinolytic Agents / adverse effects
Humans
Substances
Fibrinolytic Agents